Gregory Fraser's Stock Ratings

Truist Securities Analyst

Gregory Fraser is an analyst at Truist Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/24/2024

Overall Average Return

19.0%

Smart Score

68.7%

Overall Average Return Percentile

77th

Number of Ratings

33
Buy NowGet Alert
07/25/2024BHCBuy Now
Bausch Health Companies
$5.8819.05%$8 → $7MaintainsHoldGet Alert
04/30/2024XAIRBuy Now
Beyond Air
$0.581281.69%$10 → $8MaintainsBuyGet Alert
03/01/2024ANIPBuy Now
ANI Pharmaceuticals
$62.0328.97%$72 → $80MaintainsBuyGet Alert
02/16/2024ANIPBuy Now
ANI Pharmaceuticals
$62.0316.07%$70 → $72MaintainsBuyGet Alert
01/18/2024BTMDBuy Now
Biote
$7.8714.36%$10 → $9MaintainsBuyGet Alert
11/14/2023XAIRBuy Now
Beyond Air
$0.581627.12%$14 → $10MaintainsBuyGet Alert
11/08/2023AMRXBuy Now
Amneal Pharmaceuticals
$7.38-5.15%$6 → $7MaintainsBuyGet Alert
09/06/2023AMRXBuy Now
Amneal Pharmaceuticals
$7.38-18.7% → $6ReiteratesBuy → BuyGet Alert
08/21/2023ANIPBuy Now
ANI Pharmaceuticals
$62.0312.85% → $70ReiteratesBuy → BuyGet Alert
08/07/2023AMRXBuy Now
Amneal Pharmaceuticals
$7.38-18.7%$4 → $6MaintainsBuyGet Alert
08/03/2023CORTBuy Now
Corcept Therapeutics
$34.87-16.83%$26 → $29MaintainsHoldGet Alert
07/21/2023XAIRBuy Now
Beyond Air
$0.582317.96%$18 → $14MaintainsBuyGet Alert
07/21/2023ANIPBuy Now
ANI Pharmaceuticals
$62.03-3.27%$52 → $60MaintainsBuyGet Alert
06/06/2023NVCRBuy Now
NovoCure
$18.65409.38% → $95ReiteratesBuy → BuyGet Alert
05/26/2023EOLSBuy Now
Evolus
$12.1348.39%$14 → $18MaintainsBuyGet Alert
05/26/2023CORTBuy Now
Corcept Therapeutics
$34.87-25.44%$28 → $26MaintainsHoldGet Alert
05/26/2023ARQTBuy Now
Arcutis Biotherapeutics
$10.10296.04%$45 → $40MaintainsBuyGet Alert
05/09/2023ANIPBuy Now
ANI Pharmaceuticals
$62.03-16.17%$50 → $52MaintainsBuyGet Alert
03/29/2023AMRXBuy Now
Amneal Pharmaceuticals
$7.38-45.8%$5 → $4MaintainsBuyGet Alert
03/29/2023ARQTBuy Now
Arcutis Biotherapeutics
$10.10345.54%$50 → $45MaintainsBuyGet Alert
11/08/2022CORTBuy Now
Corcept Therapeutics
$34.87-19.7%$30 → $28MaintainsHoldGet Alert
10/28/2022NVCRBuy Now
NovoCure
$18.65446.92%$105 → $102MaintainsBuyGet Alert
09/27/2022BTMDBuy Now
Biote
$7.8727.06% → $10Initiates → BuyGet Alert
08/24/2022AERIBuy Now
Aerie Pharmaceuticals
DowngradeBuy → HoldGet Alert
08/01/2022CORTBuy Now
Corcept Therapeutics
$34.87-13.97% → $30DowngradeBuy → HoldGet Alert
07/29/2022NVCRBuy Now
NovoCure
$18.65463%$118 → $105MaintainsBuyGet Alert
07/29/2022BHCBuy Now
Bausch Health Companies
$5.88DowngradeBuy → HoldGet Alert
06/29/2022XAIRBuy Now
Beyond Air
$0.583354.23%$16 → $20MaintainsBuyGet Alert
05/17/2022CRXTBuy Now
Clarus Therapeutics Hldgs
$7 → $3MaintainsBuyGet Alert
04/14/2022ATRSBuy Now
Antares Pharma
$7 → $5.6DowngradeBuy → HoldGet Alert
01/28/2022CORTBuy Now
Corcept Therapeutics
$34.87-13.97% → $30Initiates → BuyGet Alert
01/20/2022EOLSBuy Now
Evolus
$12.13-9.32% → $11UpgradeHold → BuyGet Alert
11/12/2021XAIRBuy Now
Beyond Air
$0.582663.39%MaintainsBuyGet Alert